COLEMAN LEWIS W 4
4 · Immune Design Corp. · Filed Oct 31, 2017
Insider Transaction Report
Form 4
COLEMAN LEWIS W
Director
Transactions
- Purchase
Common Stock
2017-10-27$4.07/sh+65,000$264,752→ 125,000 total(indirect: By Trust)
Holdings
- 3,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.00 to $4.10 on October 27, 2017. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]On September 20, 2016, the reporting person filed a Form 4 which inadvertently reported that the acquisition of 50,000 shares of the Issuer's Common Stock was held directly by the reporting person. Subsequently, on December 22, 2016, the reporting person disposed of 10,000 shares. This Form 4 corrects the reporting person's holdings to reflect that the remaining 40,000 shares are held indirectly by the reporting person's trust.